Hi <<First Name>>
Welcome to the Lab Bulletin Coronavirus (COVID-19) Update.
This weekly update aims to help keep our readers updated on the latest laboratory products and news for COVID-19 screening and testing.
If you have any products, technologies or news that will be critical in battling COVID-19 then we would like to hear from you. Please send your press releases to editorial@labbulletin.com
Keep Safe!
|
|
Here's our latest news for you <<First Name>>
|
|
The SARS-CoV-2 pandemic has a wide range of effects on laboratories around the world. This includes not only the current high volume of requests for PCR tests for the novel coronavirus. It has challenged laboratories worldwide with respect to quickly adopting digital technologies to cope with the new norms of social distancing, remote work away from laboratory benches...
Excalibur Healthcare Services (“Excalibur”) announce it has created an innovative ‘freedom passport’ which can pave the way for people to mix safely in public and travel securely in large numbers without spreading Covid infection. The ‘passport’ has been developed through a pioneering partnership between Excalibur, led by Professor Sir Chris Evans, OBE, and his lateral flow diagnostics team in Cambridge, and Sensyne Health plc...
La Jolla Institute for Immunology (LJI), one of the leading research organizations dedicated to studying the immune system announced today that it has signed a licensing agreement with Leinco Technologies, Inc., a premier developer and manufacturer of leading-edge recombinant proteins, antibodies, and conjugates...
Increased pollen concentrations correlate with higher SARS-CoV-2 infection rates. When airborne pollen levels are higher, increased SARS-CoV-2 infection rates can be observed. These results were determined by a large-scale study conducted by an international team headed by researchers at the Technical University of Munich (TUM) and the Helmholtz Zentrum München...
The partnership will work towards CE marking of Aptamer Group’s AptaDx SARS-CoV-2 lateral flow rapid antigen test for professional use, to detect the SARS-CoV-2 spike protein antigen in anterior nasal swabs. Initial test analysis with laboratory samples has demonstrated excellent sensitivity being able to detect as little as 1000 virus particles per mL...
Beckman Coulter has announced that it has expanded claims for its CE-marked Access Interleukin-6 (IL-6) assay. The Access IL-6 assay is an in-vitro diagnostic test for the quantitative determination of IL-6 levels in human serum and plasma (heparin). The fully-automated assay helps physicians identify a severe inflammatory response in COVID-19 patients, often referred to as cytokine storm, and determine the risk of intubation with mechanical ventilation, in conjunction with clinical findings and the results of other laboratory testing....
|
|
Lab Bulletin is a free online resource for scientists and laboratory professionals where you can catch up on the latest news for laboratory products and services. You will also find an extensive directory of laboratory suppliers and manufacturers enabling you to contact companies quickly and easily to request further information.
Lab Bulletin also publishes three free monthly newsletters keeping you up-to-date with all of the latest laboratory products and industry news directly to your inbox. We have dedicated newsletters for Separation Science, Microscopy and Image Analysis and the Lab Bulletin Monthly Newsletter sent out to over 32,400 readers worldwide.
As a subscriber to our Coronavirus (COVID-19) Update, If you would also like to receive a copy of our Separation Science, Microscopy & Image Analysis or the Lab Bulletin monthly newsletter, simply update your subscription preferences.
|
|
|
|